Crude Oil Jumps 2 Macys Lowers Earnings Forecast
CLRB Stock | USD 0.28 0.02 7.69% |
About 55% of Cellectar Biosciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Cellectar Biosciences stock suggests that some investors are interested at this time. The current market sentiment, together with Cellectar Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cellectar Biosciences stock news signals to limit their universe of possible portfolio assets.
Cellectar |
Read at benzinga.com
![]() |
Cellectar Biosciences Fundamental Analysis
We analyze Cellectar Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellectar Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellectar Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Cellectar Biosciences is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Cellectar Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cellectar Biosciences stock to make a market-neutral strategy. Peer analysis of Cellectar Biosciences could also be used in its relative valuation, which is a method of valuing Cellectar Biosciences by comparing valuation metrics with similar companies.
Peers
Cellectar Biosciences Related Equities
BPTH | Bio Path | 6.85 | ||||
TENX | Tenax Therapeutics | 6.32 | ||||
PULM | Pulmatrix | 2.57 | ||||
BOLT | Bolt Biotherapeutics | 2.04 | ||||
NXTC | NextCure | 1.25 | ||||
BNTC | Benitec Biopharma | 2.30 | ||||
MNPR | Monopar Therapeutics | 3.40 | ||||
CAPR | Capricor Therapeutics | 4.91 |
Complementary Tools for Cellectar Stock analysis
When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |